Conference Coverage

Intensified rifampicin boosts outcomes in TB/HIV coinfection


 

AT AIDS 2016

References

The trial was funded by the European and Developing Countries Clinical Trials Partnership. Dr. Merle reported having no financial conflicts of interest.

bjancin@frontlinemedcom.com

Pages

Next Article:

Don’t delay treatment for patients with TB and HIV